View of Simvastatin and Alendronate sodium repurposing for cancer as HER2, EGFR kinase and AR potential inhibitors: In silico approach

Return to Article Details Simvastatin and Alendronate sodium repurposing for cancer as HER2, EGFR kinase and AR potential inhibitors: In silico approach Download Download PDF